Cargando…
Costs of Parkinson’s Disease in a Privately Insured Population
BACKGROUND: This is the first analysis to estimate the costs of commercially insured patients with Parkinson’s disease (PD) in the USA. Prior analyses of PD have not examined costs in patients aged under 65 years, a majority of whom are in the workforce. OBJECTIVE: Our objective was to estimate dire...
Autores principales: | Johnson, Scott J., Kaltenboeck, Anna, Diener, Melissa, Birnbaum, Howard G., Grubb, ElizaBeth, Castelli-Haley, Jane, Siderowf, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757266/ https://www.ncbi.nlm.nih.gov/pubmed/23907717 http://dx.doi.org/10.1007/s40273-013-0075-0 |
Ejemplares similares
-
Direct Costs of Opioid Abuse in an Insured Population in the United States
por: White, Alan G., et al.
Publicado: (2005) -
Direct Costs of Opioid Abuse in an Insured Population in the United States
por: WHITE, ALAN G., et al.
Publicado: (2020) -
Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA
por: Chu, David S, et al.
Publicado: (2013) -
Uptake and cost of influenza vaccines in a private health insured South African population
por: Solanki, Geetesh, et al.
Publicado: (2018) -
Physician cost experience under private health insurance programs
por: Dyckman, Zachary
Publicado: (1992)